Page last updated: 2024-11-02

papaverine and Akinetic-Rigid Variant of Huntington Disease

papaverine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies

Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.

Research Excerpts

ExcerptRelevanceReference
"Papaverine treatment improved spatial and object recognition memories in R6/1 mice, and significantly increased pGluA1 and pCREB levels in R6/1 mice hippocampus."1.39PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model. ( Alberch, J; Arumí, H; Carretón, O; Giralt, A; Pérez-Navarro, E; Saavedra, A; Tyebji, S, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giralt, A1
Saavedra, A1
Carretón, O1
Arumí, H1
Tyebji, S1
Alberch, J1
Pérez-Navarro, E1

Other Studies

1 other study available for papaverine and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model.
    Hippocampus, 2013, Volume: 23, Issue:8

    Topics: Analysis of Variance; Animals; CREB-Binding Protein; Disease Models, Animal; Gene Expression Regulat

2013